PortViewPortView
Assertio logo

Assertio (ASRT) Stock Analysis

NASDAQHealthcareDrug Manufacturers - Specialty & Generic

$23.50+0.00%
1-year price historyRange $0.97 – $23.50
52-week range$23.50
$8.61$23.50

What Assertio does

Assertio Holdings, Inc. is a specialized pharmaceutical company focused on developing and commercializing therapeutic solutions across key medical domains, including neurology, hospital care, and pain and inflammation management. Among its portfolio, Assertio offers INDOCIN, available as both an oral solution and a suppository. This medication addresses conditions such as moderate to severe rheumatoid arthritis (including acute flare-ups), ankylosing spondylitis, osteoarthritis, acute painful shoulder, and gouty arthritis. The company's offerings also encompass CAMBIA, an NSAID specifically formulated to alleviate symptoms associated with migraine headaches, including nausea, light sensitivity (photophobia), and sound sensitivity (phonophobia). Zipsor, another NSAID, is indicated for managing mild to moderate acute pain. For more significant short-term pain relief, SPRIX, also an NSAID, provides analgesia comparable to opioid-level treatments for moderate to moderately severe pain. Rounding out its product line is Otrexup, a prescription methotrexate delivered via a convenient single-dose auto-injector. This therapy targets severe, active rheumatoid arthritis in adults and active polyarticular juvenile idiopathic arthritis in pediatric patients. Initially incorporated as Assertio Therapeutics, Inc. in 1995, the organization rebranded to Assertio Holdings, Inc. in May 2020 and maintains its corporate headquarters in Lake Forest, Illinois.

Key metrics

Market cap
$151.86M
P/E (TTM)
-7.10
EPS (TTM)
$-3.31
Beta
0.53
Dividend yield
0.00%
Revenue / share
$15.88
50-day avg
$21.99
200-day avg
$14.90
52-week high
$23.50
52-week low
$8.61
CEO
Mark L. Reisenauer

ETFs linked to ASRT

Broad-market and Healthcare sector ETFs an investor holding Assertio is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ASRT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ASRT in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Assertio?
Assertio trades under the ticker ASRT on NASDAQ.
Which exchange is ASRT listed on?
ASRT is listed on NASDAQ.
What sector does Assertio operate in?
Assertio is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
How can PortView help analyze ASRT in a portfolio?
PortView shows ASRT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.